The Iberoamerican Journal of Medicine (Iberoam J Med), founded in 2019, has swiftly established itself as a vital contributor to the dissemination of high-quality medical research. In just a few years, it has gained recognition and visibility in prestigious academic platforms, becoming a trusted source for healthcare professionals and researchers in the Ibero-American region and beyond. Indexed in SciELO, the Directory of Open Access Journals (DOAJ), Latindex, and Redalyc, IJM stands as a testament to the power of open access publishing in advancing medical science.
Iberoam J Med journey began with a mission to bridge gaps in medical knowledge and foster collaboration across the Ibero-American region. Its first volume, published in 2019, laid the foundation for what has become a reputable forum for discussing diverse medical topics. The journal’s scope encompasses clinical medicine, public health, biomedical sciences, and interdisciplinary research, reflecting the complexity and breadth of modern healthcare challenges. Since its inception, the journal has attracted significant attention from the scientific community. By the end of 2024, it had received 518 article submissions, of which 228 were accepted for publication. This acceptance rate of 44.01% underscores Iberoam J Med rigorous peer-review process and commitment to publishing only high-quality research. Such selectivity ensures that readers can trust the validity and relevance of the studies featured in the journal.
One of the pivotal achievements of Iberoam J Med is its inclusion in renowned indexing platforms such as SciELO, which enhances the visibility and accessibility of Iberoam J Med articles. This indexing reflects Iberoam J Med compliance with stringent academic standards and its contribution to scientific advancement in Latin America and the Caribbean. Similarly, the Directory of Open Access Journals (DOAJ) highlights Iberoam J Med commitment to open access principles, ensuring its research reaches a global audience and fosters knowledge sharing. Latindex underscores Iberoam J Med adherence to editorial quality and transparency, essential for building trust among researchers and institutions, while Redalyc positions Iberoam J Med within a network of academic journals dedicated to open dissemination, further solidifying its reputation in the scientific community.
The adoption of an open access model has been instrumental in Iberoam J Med success. By eliminating subscription fees, the journal democratizes access to cutting-edge research, enabling healthcare practitioners, academics, and policymakers to stay informed about the latest developments. This model is particularly impactful in regions where financial constraints often limit access to scholarly publications. Moreover, open access enhances the citation potential of articles, increasing their impact and fostering wider dissemination of scientific findings. For IJM, this approach aligns with its mission to advance medical science and improve healthcare outcomes across the Ibero-American region and beyond.
Iberoam J Med influence in the scientific community is reflected in its steadily increasing citation metrics. According to Google Scholar, the journal received 81 citations in 2020, 156 in 2021, 203 in 2022, 189 in 2023, 223 in 2024, and 6 in early 2025 [
Iberoam J Med peer-review process is the cornerstone of its credibility. Each submission undergoes a meticulous review by experts in the relevant field, ensuring that only studies meeting the highest standards of scientific integrity are published. This commitment to quality has earned Iberoam J Med the trust of authors and readers alike. The journal also emphasizes ethical publishing practices, adhering to international guidelines to prevent issues such as plagiarism, data fabrication, and conflicts of interest. By upholding these standards, IJM contributes to the integrity of the scientific record.
The inclusive approach to medical research is evident in the diversity of topics covered. From groundbreaking clinical trials and innovative treatment modalities to public health strategies and biomedical advancements, the journal serves as a platform for addressing pressing healthcare challenges. It also welcomes interdisciplinary studies that explore the intersection of medicine with fields such as technology, sociology, and economics, reflecting the interconnected nature of modern healthcare.
Despite its achievements, Iberoam J Med faces challenges common to many academic journals. Securing sustainable funding for open access publishing is a persistent concern, as is maintaining a steady flow of high-quality submissions. Additionally, the journal must navigate the competitive landscape of academic publishing, where attracting top-tier research can be challenging. Looking ahead, Iberoam J Med aims to expand its reach and influence by enhancing its digital presence, leveraging advanced tools to improve accessibility and discoverability, strengthening international collaborations, and promoting early-career researchers by providing platforms for young scientists to share their work. Furthermore, the journal is committed to highlighting research that addresses the unique healthcare challenges faced by the Ibero-American region.
The Iberoamerican Journal of Medicine has made remarkable strides since its launch in 2019. Its dedication to quality, open access, and regional relevance has established it as a key player in the landscape of medical publishing. By continuing to uphold its standards and adapt to the evolving needs of the scientific community, IJM is poised to make an enduring impact on healthcare research and practice. As the journal moves forward, it invites researchers, clinicians, and policymakers to join its mission of advancing medical knowledge for the benefit of all. Together, they can ensure that IJM remains a beacon of scientific excellence in the years to come.
The authors have no conflict of interest to declare. The authors declared that this study has received no financial support.